Similar articles

• Clinical review of chondroitin sulfate in osteoarthritis.

  Uebelhart D. Uebelhart D. Osteoarthritis Cartilage. 2008;16 Suppl 3:S19-21. doi: 10.1016/j.joca.2008.06.006. Epub 2008 Jul 31. Osteoarthritis Cartilage. 2008. PMID: 18674931 Review.
• The effect of glucosamine sulphate on osteoarthritis: design of a long-term randomised clinical trial [ISRCTN54513166].

  Rozendaal RM, Koes BW, Weinans H, Uitterlinden EJ, van Osch GJ, Ginai AZ, Verhaar JA, Bierma-Zeinstra SM. Rozendaal RM, et al. BMC Musculoskelet Disord. 2005 Apr 26;6:20. doi: 10.1186/1471-2474-6-20. BMC Musculoskelet Disord. 2005. PMID: 15850497 Free PMC article. Clinical Trial.
• Review: diacerein is more effective than placebo and is as effective as NSAIDs for knee and hip osteoarthritis.

  Hunter DJ, Wise B. Hunter DJ, et al. Evid Based Med. 2007 Jun;12(3):74. doi: 10.1136/ebm.12.3.74. Evid Based Med. 2007. PMID: 17537882 No abstract available.
• Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis.

  Altman RD, Abadie E, Avouac B, Bouvenot G, Branco J, Bruyere O, Calvo G, Devogelaer JP, Dreiser RL, Herrero-Beaumont G, Kahan A, Kreutz G, Laslop A, Lemmel EM, Menkes CJ, Pavelka K, Van De Putte L, Vanhaelst L, Reginster JY; Group for Respect of Excellence and Ethics in Science (GREES). Altman RD, et al. Osteoarthritis Cartilage. 2005 Jan;13(1):13-9. doi: 10.1016/j.joca.2004.10.012. Osteoarthritis Cartilage. 2005. PMID: 15639632 Review.
• OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis.

  Gossec L, Hawker G, Davis AM, Maillefert JF, Lohmander LS, Altman R, Cibere J, Conaghan PG, Hochberg MC, Jordan JM, Katz JN, March L, Mahomed N, Pavelka K, Roos EM, Suarez-Almazor ME, Zanoli G, Dougados M. Gossec L, et al. J Rheumatol. 2007 Jun;34(6):1432-5. J Rheumatol. 2007. PMID: 17552070